[Effectiveness of lincomycin therapy in 40 cases of beta-hemolytic streptococcus infections, resistant or allergic to penicillin].
D000293:Adolescent; D000328:Adult; D000667:Ampicillin / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004342:Drug Hypersensitivity; D004361:Drug Tolerance; D004893:Erythema Nodosum / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008034:Lincomycin / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010403:Penicillin Resistance; D010406:Penicillins / Q000009:adverse effects*; D012216:Rheumatic Diseases / Q000517:prevention & control; D013290:Streptococcal Infections / Q000188:drug therapy*; D013291:Streptococcus / Q000187:drug effects
D010406:Penicillins; D000667:Ampicillin; D008034:Lincomycin
Efficacia del trattamento con lincomicina in 40 casi di infezione da streptococco  -emolitico resistenti od allergici alla penicillina.